Papers

8

Total Citations

214

H-Index

7

About

Ryan P. Goepfert is a leading surgical oncologist specializing in the treatment of head and neck cancers, with a particular focus on oropharyngeal squamous cell carcinoma. His research centers on optimizing functional outcomes—especially swallowing—after treatment, and he is a key figure in the comparative effectiveness of transoral robotic surgery (TORS) versus radiation therapy. Goepfert’s landmark 2019 study (87 citations) demonstrated that TORS with neck dissection can preserve swallowing function better than nonsurgical therapy in low- to intermediate-risk oropharyngeal cancer patients. He also led the 2025 ASCO guideline on TORS in multidisciplinary care (38 citations), establishing evidence-based standards for its use. His work has shown that TORS reduces gastrostomy tube dependence and weight loss (21 citations), and he has advanced intraoperative techniques, such as combining TORS with trans-oral ultrasound for precise tumor excision. With over 200 cumulative citations, Goepfert’s research directly informs clinical decision-making, helping patients and providers choose treatments that maximize cancer control while minimizing long-term swallowing toxicity.

Research Focus

Key Achievements

7
H-Index
8
Papers
214
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
Dysphagia After Primary Transoral Robotic Surgery With Neck Dissection vs Nonsurgical Therapy in Patients With Low- to Intermediate-Risk Oropharyngeal Cancer
87 citations · 2019
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 45
🏛 Institutions: The University of Texas MD Anderson Cancer Center, University of California, San Francisco

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago